News and Public Documents

CGS Buscopan Position Statement

October 5, 2019 Canadian Glaucoma Society Evidence-Based Recommendations For The Risk Of Acute Angle Closure Glaucoma With Routine Use Of Hyoscine-N-Butylbromide (Buscopan) For Gastroenterological Procedures Background Hyoscine-n-butylbromide (Buscopan) is...

CGS & COS – Response Letters To CADTH On MIGS – FEB 2019

Click here to read the CADTH recommendations Report on MIGS. Canadian Glaucoma Society (CGS) Response Letter To The Canadian Agency For Drugs And Technologies In Health (CADTH)...

CGS History

Although the Canadian Glaucoma Society (CGS) was officially founded in 1989, the origins of the CGS can be traced back to the early 1970s.  Fellows of...

COS & CGS MIGS Position Statement December 2017

Canadian Ophthalmological Society (COS) & Canadian Glaucoma Society (CGS)   Micro-Invasive Or Minimally Invasive Glaucoma Surgery (MIGS) Position Statement December 2017 Current surgical treatments for glaucoma are...

CGS Legacy Logo

CSS Legacy Logo The first logo for the CGS was conceived in 2003, many years after the founding of the Society, by our first President, Dr Raymond...

CGS Statement Of “MIGS Advocacy Committee” June 2017

CGS Statement of “MIGS Advocacy Committee” June 2017 Committee Members:  Ike Ahmed, Bryce Ford, Cindy Hutnik, Marcelo Nicolela, Jamie Taylor, Hady Saheb (Group Chair) Current surgical treatments for glaucoma are...